Desq Long
Sign in

Company

BIOCRYST PHARMACEUTICALS INC

BCRX · CIK 0000882796

SEC FORM 4
$12,493.60

BIOCRYST PHARMACEUTICALS INC (BCRX)

Acquisition (code A) of 1,288 shares at $9.70 per share.

Reporting Person Frank Steven · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0000882796-26-000057 · filed 2026-09-02 · View filing →

SEC FORM 4
$6,246.80

BIOCRYST PHARMACEUTICALS INC (BCRX)

Acquisition (code A) of 644 shares at $9.70 per share.

Reporting Person McKee Amy E · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0000882796-26-000059 · filed 2026-09-02 · View filing →

SEC FORM 4
$11,242.30

BIOCRYST PHARMACEUTICALS INC (BCRX)

Acquisition (code A) of 1,159 shares at $9.70 per share.

Reporting Person MILANO VINCENT · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0000882796-26-000061 · filed 2026-09-02 · View filing →

SEC FORM 4
$12,493.60

BIOCRYST PHARMACEUTICALS INC (BCRX)

Acquisition (code A) of 1,288 shares at $9.70 per share.

Reporting Person Milne Jill C. · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0000882796-26-000063 · filed 2026-09-02 · View filing →

SEC FORM 4
$6,246.80

BIOCRYST PHARMACEUTICALS INC (BCRX)

Acquisition (code A) of 644 shares at $9.70 per share.

Reporting Person Stonehouse Jon P · Transaction Code A

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0000882796-26-000065 · filed 2026-09-02 · View filing →